Expression of protein-kinase C isoforms and interleukin-1β in myofibrillar myopathy

Neurology

Volumn 62, Issue 10, 2004, Pages 1778-1782

  Vattemi, G ^a   Tonin, Paola ^a,b   Mora, M ^c   Filosto, M ^a   Morandi, L ^c   Savio, C ^a   Dal Pra, I ^b   Rizzuto, N ^a   Tomelleri, G ^a  

^a Policlinico GB Rossi ^*  (Italy)

^b Policlinico GB Rossi   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; INTERLEUKIN 1BETA; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON;

ADULT; ARTICLE; CASE REPORT; CYTOKINE RELEASE; ELECTRON MICROSCOPY; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; MUSCLE FIBRIL; MYOFIBRILLAR MYOPATHY; MYOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 2442704096     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000125197.70310.8E     Document Type: Article

References (46)

1. Nakano S, Engel AG, Waclawik AJ, Emslie-Smith AM, Busis NA. Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol 1996;55:549-562.
2. Amato AA, Kagan-Hallet K, Jackson CE, et al. The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis. Neurology 1998;51:1646-1655.
3. Goebel HH. Desmin-related neuromuscular disorders. Muscle Nerve 1995;18:1306-1320.
4. Engel AG. Myofibrillar myopathy. Ann Neurol 1999;46:681-683.
5. Goldfarb LG, Park KY, Cerenakova L, et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998;19:402-403.
6. Munoz-Marmol AM, Strassler G, Isamat M, et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci USA 1998;95:11312-11317.
7. Sjoberg G, Saavedra-Matiz CA, Rosen DR, et al. A missense mutation in the rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet 1999;8:2191-2198.
8. Dalakas M, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in desmin gene. N Engl J Med 2000;342:770-780.
9. Sugawara M, Kato K, Komatsu M, et al. A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates. Neurology 2000;55:986-990.
10. Vicart P, Caron A, Guicheney P, et al. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 1998;20:92-95.
11. Nakano S, Engel AG, Akiguchi I, Kimura J. Myofibrillar myopathy. III. Abnormal expression of cyclin-dependent kinases and nuclear proteins. J Neuropathol Exp Neurol 1997;56:850-856.
12. II protein kinase C is required for the G2/M phase transition of cell cycle. J Biol Chem 1996;271:15045-15053.
13. Tang S, Morgan KG, Parker C, Ware JA. Requirement for protein kinase C theta for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells. J Biol Chem 1997;272:28704-28711.
14. Hofmann J, O'Connor PM, Jackman J, et al. The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents. Biochem Biophys Res Commun 1994;199:937-943.
15. Usui T, Yoshida M, Abe K, Osada H, Isono K, Beppu T. Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J Cell Biol 1991;115:1275-1282.
16. Abe K, Yoshida M, Usui T, Horinouchi S, Beppu T. Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases. Exp Cell Res 1991;192:122-127.
17. Kolomytkin OV, Marino AA, Sadasivan KK, Wolf RE, Albright JA. Intracellular signaling mechanisms of interleukin-1 beta in synovial fibroblasts. Am J Physiol 1999;276:C9-15.
18. Ganz MB, Saksa B, Saxena R, Hawkins K, Sedor JR. PDGF and IL-1 induce and activate specific protein kinase C isoforms in mesangial cells. Am J Physiol 1996;271:F108-113.
19. Musial A, Mandal A, Coroneos E, Kester M. Interleukin-1 and endothelin stimulate distinct species of diglycerides that differentially regulate protein kinase C in mesangial cells. J Biol Chem 1995;270:21632-21638.
20. Kracht M, Heiner A, Resch K, Szamel M. Interleukin-1-induced signaling in T-cells. Evidence for the involvement of phosphatases PP1 and PP2A in regulating protein kinase C-mediated protein phosphorylation and interleukin-2 synthesis. J Biol Chem 1993;268:21066-21072.
21. Baracos V, Rodeman HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leucocyte pyrogen (interleukin-1). N Engl J Med 1983;308:553-558.
22. Clowes GHA, George BC, Villee CA, Saravis CA. Muscle proteolysis induced by circulating peptide in patients with sepsis or trauma. N Engl J Med 1983;308:545-552.
23. DeBleecker JL, Engel AG, Ertl BB. Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 1996;55:563-577.
24. Li M, Dalakas MC. Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations. Ann Neurol 2001;49:532-536.
25. Jaken S. Protein kinase isozymes and substrates. Curr Opin Cell Biol 1996;8:18-173.
26. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implication for cellular regulation. Nature 1988;334:661-665.
27. Boczan J, Boros S, Mechler F, Kovacs L, Birò T. Differential expression of protein kinase C isozymes during proliferation and differentiation of human skeletal muscle cells in vitro. Acta Neuropathol 2000;99:96-104.
28. Goodnight J, Mischak H, Mushinski JF. Selective involvement of protein kinase C isozymes in differentiation and neoplastic transformation. Adv Cancer Res 1994;64:159-209.
29. Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stress. Free Radic Biol Med 2000;28:1349-1361.
30. Collas P, Thompson L, Fields AP, Poccia DL, Courvalin JC. Protein kinase C-mediated interphase lamin B phosphorylation and solubilation. J Biol Chem 1997;272:21274-21280.
31. Beckmann R, Buchner K, Jungblut PR, et al. Nuclear substrates of protein kinase C. Eur J Biochem 1992;210:45-51.
32. Takai Y, Ogawara M, Tomono Y, et al. Mitosis-specific phosphorylation of vimentin by protein kinase C coupled with reorganization of intracellular membranes. J Cell Biol 1996;133:141-149.
33. Ogawara M, Inagaki N, Tsujimura K, et al. Differential targeting of protein kinase C and CaM kinase II signalings to vimentin. J Cell Biol 1995;131:1055-1066.
34. Collas P. Sequential PKC- and Cdc2-mediated phosphorylation events elicit zebrafish nuclear envelope disassembly. J Cell Sci 1999;112:977-987.
35. Caron A, Chapon F. Desmin phosphorylation abnormalities in cytoplasmic body and desmin-related myopathies. Muscle Nerve 1999;22:1122-1125.
36. Rappaport L, Contard F, Samuel JL, et al. Storage of phosphorylated desmin in a familial myopathy. FEBS Lett 1988;231:421-425.
37. Inagaki M, Gonda Y, Matsuyama M, Nishizawa K, Nishi Y, Sato C. Intermediate filament reconstitution in vitro. The role of phosphorylation on the assembly-disassembly of desmin. J Biol Chem 1988;263:5970-5978.
38. Kitamura S, Ando S, Shibata M, Tanabe K, Sato C, Inagaki M. Protein kinase C phosphorylation of desmin at four serine residues within the non-alpha-helical head domain. J Biol Chem 1989;264:5674-5678.
39. Ascer E, Mohan C, Gennaro M, Cupo S. Interleukin-1β and thromboxane release after skeletal muscle ischaemia and reperfusion. Ann Vasc Surg 1992;6:69-73.
40. Gherardi R, Florea-Strat A, Fromont G, Poron F, Sabourin JC, Authier FJ. Cytokine expression in the muscle of HIV-infected patients: evidence for IL-1α accumulation in mitochondria of AZT fibers. Ann Neurol 1994;36:752-758.
41. Schubert W, Kontozis L, Sticker G, Schwan H, Haraldsen G, Jerusalem F. Immunofluorescent evidence for presence of interleukin-1 in normal and diseased human skeletal muscle. Muscle Nerve 1988;11:890-892.
42. Tews DS, Goebel HH. Cytokine expression profile in idiopathic inflammatory myopathy. J Neuropathol Exp Neurol 1996;55:342-347.
43. Authier FJ, Mhiri C, Chazaud B, et al. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibers showing ischaemic and regenerative changes. Neuropathol Appl Neurobiol 1997;23:132-140.
44. Belec L, Authier FJ, Chazaud B, Piedouillet C, Barlovatz-Meimon G, Gherardi RK. Interleukin (IL)-1 beta and IL-1 beta mRNA expression in normal and diseased skeletal muscle assessed by immunocytochemistry, immunoblotting and reverse transcriptase-nested polymerase chain reaction. J Neuropathol Exp Neurol 1997;56:651-663.
45. Authier FJ, Chazaud B, Mhiri C, et al. Interleukin-1 expression in normal motor endplates and muscle fibers showing neurogenic changes. Acta Neuropathol 1997;94:272-279.
46. Cannon JG, Fielding RA, Fiatarone MA, Orencole SF, Dinarello CA, Evans WJ. Increased interleukin-1β in human skeletal muscle after exercise. Am J Physiol 1989;257:R451-455.